Understanding Genetic Transmission: Why HPP Is Inherited Rather Than Contagious

Hypophosphatasia (HPP) is a rare metabolic bone disorder caused by mutations in the ALPL gene. These mutations lead to reduced activity of the enzyme tissue-nonspecific alkaline phosphatase (TNSALP), resulting in improper mineralization of bone and teeth. Because HPP stems from genetic changes passed down through families, it is inherited—not an infection you can catch or spread.

In this article, we’ll explain:

• How HPP is passed from parents to children
• Why it isn’t contagious
• The different inheritance patterns and their impact
• How HPP is diagnosed and managed
• Practical next steps, including free symptom checking and when to consult a doctor

1. The Basics: Genetic Mutations vs. Contagious Agents

Infectious diseases are caused by bacteria, viruses, fungi or parasites that can transfer from person to person. Genetic disorders, by contrast, result from variations in our DNA. Key distinctions:

• Genetic disorders

  • Origin: Changes (mutations) in one or more genes
  • Transmission: Passed biologically from parent(s) to child(ren)
  • Prevention: Genetic counseling; no “quarantine” needed

• Contagious diseases

  • Origin: Microorganisms that multiply and spread between hosts
  • Transmission: Direct contact, airborne droplets, bodily fluids, surfaces
  • Prevention: Hygiene, vaccines, isolation

Because HPP arises from a defect in the ALPL gene located on chromosome 1, it cannot jump from person to person like flu or measles. Instead, it is inherited according to specific genetic rules.

2. Modes of Inheritance in Hypophosphatasia

Geneticists have identified two main inheritance patterns for HPP:

A. Autosomal Recessive (AR) Inheritance

• Mechanism: A child must inherit two mutated copies of ALPL (one from each parent) to develop HPP.
• Carriers: Parents who each carry one mutated copy are typically healthy or have very mild signs.
• Risk: With two carrier parents, each child has:
  • 25% chance of having HPP (two mutated copies)
  • 50% chance of being an asymptomatic carrier (one mutated copy)
  • 25% chance of inheriting two normal copies

B. Autosomal Dominant (AD) Inheritance

• Mechanism: A single mutated copy of ALPL can be enough to cause HPP.
• Family transmission: An affected parent has a 50% chance of passing the mutated gene to each child.
• Variable expressivity: Even within the same family, severity can range from very mild to more significant bone or dental issues.

Clinical Variability

• Perinatal (lethal): AR form, often severe, may lead to life-threatening complications at or before birth.
• Infantile: AR form, signs appear before 6 months; includes low muscle tone and poor feeding.
• Childhood: Both AR and AD forms; delayed walking, fractures, dental problems.
• Adult: Often AD form; recurring stress fractures, thigh bone pain, early tooth loss.
• Odontohypophosphatasia: Mainly dental symptoms, can be AR or AD.

3. Why HPP Is Not Contagious

Several factors make it clear HPP cannot spread person to person:

• No infectious agent: Mutated DNA in the ALPL gene is a structural change in your chromosomes—not a microbe.
• Family patterns: Pedigree charts show HPP tracking through blood relatives, not casual contacts.
• Genetic testing: Confirmed mutations in ALPL correlate with symptoms, independent of exposure to affected individuals.

In everyday life, you cannot “catch” HPP by being around someone with the condition, sharing utensils, or touching surfaces. It is a lifelong, inherited trait.

4. Diagnosis: From Symptoms to Genetic Testing

Early recognition and diagnosis help guide management. Typical steps include:

1. Clinical Evaluation

   • Growth delays, muscle weakness, bone pain
   • Early loss of baby teeth
   • Fractures with minimal trauma

2. Laboratory Tests

   • Low alkaline phosphatase (ALP) activity in blood
   • Elevated levels of substrates such as phosphoethanolamine (PEA)

3. Imaging

   • X-rays may show rickets-like changes or fractures.

4. Genetic Testing

   • Sequencing of the ALPL gene to identify specific mutations
   • Confirms inheritance pattern (AR vs. AD)
   • Enables testing of family members

5. Management and Treatment Options

While there is no cure that reverses gene mutations, several approaches help manage symptoms and improve quality of life:

• Enzyme Replacement Therapy (ERT)

  • Asfotase alfa, a synthetic form of TNSALP, replaces the missing enzyme
  • FDA-approved for perinatal, infantile and juvenile-onset HPP

• Orthopedic Care

  • Fracture management, bone support braces, physical therapy to strengthen muscles

• Dental Care

  • Regular check-ups to manage early tooth loss and prevent gum disease

• Pain Management

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) or other medications under medical supervision

• Nutrition and Lifestyle

  • Adequate calcium and vitamin D intake (under doctor guidance)
  • Low-impact exercise to maintain bone strength

6. Addressing Common Questions

Q: Is Hypophosphatasia hereditary or contagious?
A: HPP is hereditary. It is caused by genetic mutations in the ALPL gene and passed from parent(s) to child. It is not contagious.

Q: Can carriers show any symptoms?
A: Some carriers, especially in the AD form, may have mild symptoms such as early tooth loss or mild bone pain. Many carriers remain asymptomatic.

Q: Should family members be tested?
A: Genetic counseling and testing can clarify carrier status, inheritance risks and guide family planning decisions.

7. Next Steps: Symptom Checking and Professional Guidance

If you or a loved one have symptoms like persistent bone pain, frequent fractures, or early tooth loss, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool is designed to help you understand possible causes before seeing a healthcare professional.

Remember, online tools do not replace a medical evaluation. If you experience severe pain, breathing problems, poor feeding (in infants), or any life-threatening signs, speak to a doctor immediately or go to the nearest emergency department.

8. Talking to Your Healthcare Team

• Bring a detailed family history, noting any relatives with early fractures or dental issues.
• Ask your doctor about genetic testing and counseling services.
• Discuss the potential benefits and risks of enzyme replacement therapy.
• Inquire about specialists—endocrinologists, geneticists, orthopedic surgeons and dentists experienced with HPP.

9. Living with Hypophosphatasia

With appropriate care and monitoring, many individuals with HPP lead active, fulfilling lives. Key strategies:

• Stay on top of regular bone density scans and dental checks.
• Work with physical therapists to tailor exercise plans that support bone health without risking fractures.
• Seek support groups or online communities for emotional support and practical tips.

Conclusion

Hypophosphatasia is a genetic condition inherited in autosomal recessive or dominant patterns, depending on the specific mutation in the ALPL gene. It is not contagious—no amount of exposure to someone with HPP can transmit the disorder. Early diagnosis through laboratory tests and genetic screening, combined with targeted treatments such as enzyme replacement therapy, can greatly improve outcomes. If you suspect HPP or have concerning symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, and always speak to a doctor about anything that could be life-threatening or serious.